The FDA is requiring updated labeling for tranexamic acid injection to emphasize the risk of serious harm, including death, if administered incorrectly via spinal injection. Tranexamic acid injection ...
December 17, 2010 — Dolasetron mesylate (Anzemet; Aventis Pharmaceuticals) should no longer be used for the prevention of chemotherapy-induced nausea and vomiting because of an increased risk for ...
Polysubstance use has become a defining feature of the U.S. overdose crisis in the past decade. While not every overdose involves multiple substances, a significant and growing proportion includes ...
Discontinuing obesity medicines often means the weight comes back and people lose the cardiovascular and metabolic benefits conferred by the drugs.
Weight loss drugs are popular for helping patients quickly shed pounds Drugs like Ozempic are controversial for their side effects Side effects of some drugs can range from nausea to kidney failure ...
5don MSN
What obesity drugmakers see next in the market: More pills, easier access and drug combinations
CNBC spoke to executives from Eli Lilly, Novo Nordisk, Pfizer and other drugmakers at the annual JPMorgan Healthcare ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results